24 Themis

CES 2021: CareOS Earns Third CES Innovation Award Three Years in a Row, This Time for Its Themis Smart Mirror

Retrieved on: 
Monday, January 11, 2021
Articles, Health sciences, Health, Consumer Electronics Show, Preventive healthcare, 24 Themis, Mental health

Themis is the new, connected mirror from CareOS that acts as a personal wellness assistant.

Key Points: 
  • Themis is the new, connected mirror from CareOS that acts as a personal wellness assistant.
  • Themis supports the full spectrum of home health and wellness including hygiene, mental health, skincare, and preventive healthcare.
  • With Themis, CareOS celebrates the third year in a row of winning CES Innovation Awards.
  • Last year, the CareOS Poseidon smart mirror was a CES innovation Awards Honoree.

DGAP-News: Themis Beteiligungs-Aktiengesellschaft announces partial sale of existing shares in Dermapharm Holding SE via Accelerated Bookbuilding

Retrieved on: 
Tuesday, October 13, 2020
Corporate finance, Bookrunner, Initial public offering, Book building, THEMIS, 24 Themis, Academic disciplines, Astronomy, Economy

Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, intends to place 5,384,000 shares in Dermapharm Holding SE (ISIN DE000A2GS5D8), corresponding to 10.0% of the outstanding share capital, by way of an Accelerated Bookbuilding, which is to commence immediately following the publication of this release, via Berenberg as Sole Global Coordinator and Sole Bookrunner.

Key Points: 
  • Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, intends to place 5,384,000 shares in Dermapharm Holding SE (ISIN DE000A2GS5D8), corresponding to 10.0% of the outstanding share capital, by way of an Accelerated Bookbuilding, which is to commence immediately following the publication of this release, via Berenberg as Sole Global Coordinator and Sole Bookrunner.
  • The partial sale of shares is primarily aimed at increasing the free float and the trading volume in Dermapharm Holding SE.
  • Aside from Themis Beteiligungs-Aktiengesellschaft's announced sale of shares in Dermapharm Holding SE, Themis Beteiligungs-Aktiengesellschaft does currently not intend to further decrease its position as main shareholder in Dermapharm Holding SE.
  • Therefore, Themis Beteiligungs-Aktiengesellschaft committed to a 12 month lock-up following the envisaged placement.